Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 7;24(1):71.
doi: 10.1186/s12933-025-02612-z.

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity

Affiliations
Review

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity

Bas M van Dalen et al. Cardiovasc Diabetol. .

Abstract

The rising prevalence of obesity and its association with heart failure with preserved ejection fraction (HFpEF) highlight an urgent need for a diagnostic approach tailored to this population. Diagnosing HFpEF is hampered by the lack of a single non-invasive diagnostic criterion. While this makes a firm diagnosis of HFpEF already notoriously difficult in the general population, it is even more challenging in individuals with obesity. The challenges stem from a range of factors, including the use of body mass index as a conceptually suboptimal indicator of health risks associated with increased body mass, symptom overlap between HFpEF and obesity, limitations in physical examination, difficulties in electrocardiographic and echocardiographic evaluation, and reduced diagnostic sensitivity of natriuretic peptides in individuals with obesity. In this review, we examine these diagnostic challenges and propose a diagnostic algorithm specifically tailored to improve the accuracy and reliability of HFpEF diagnosis in this growing patient demographic.

Keywords: Diagnosis; Echocardiography; Heart failure with preserved ejection fraction; Natriuretic peptides; Obesity.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The institution of Dr. De Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer received travel support from Abbott, Cardior Pharmaceuticals GmbH, and NovoNordisk. Dr Brugts reports speaker engagements and/or advisory to Astra Zeneca, Abbott, Bayer, Boehringer Ingelheim, Novartis and Vifor outside the submitted work (3 year period). The institution of Dr. Van Dalen received research grants from Biotronik SE & Co. KG, Boehringer Ingelheim, Pfizer, Daiichi Sankyo, Sanofi and Novo Nordisk.

Figures

Fig. 1
Fig. 1
Adjusted Cornell criteria for left ventricular hypertrophy on electrocardiogram. Electrocardiogram of a 60-year-old male patient with obesity class 3 that meets the criteria for left ventricular hypertrophy based on the adjusted Cornell voltage*BMI, (RaVL + SV3)*BMI ≥ 700 mm*kg/m2. The diagnosis of left ventricular hypertrophy was confirmed by an echocardiogram. Note that none of the other criteria were positive. BMI, body mass index.
Fig. 2
Fig. 2
Measurement of left atrial strain. LA function based on the three phases of the LA cycle: LA reservoir strain, LA conduit strain, and LA contractile strain. LA, Left atrial
Fig. 3
Fig. 3
Hypothetical scheme for an obesity-adjusted HFpEF score in individuals with BMI ≥ 30 kg/m2. Similar to the HFA-PEFF scoring system, each domain can provide up to 2 points: 2 points are awarded if any major criterion in that domain is met, or 1 point if no major criteria are met but at least one minor criterion is fulfilled. Even if multiple major criteria are satisfied within the same domain, the maximum contribution from that domain remains 2 points. Similarly, if multiple minor criteria are met without any major ones, the domain still only contributes 1 point. Points are not cumulative within the same domain and are only combined when they come from different domains. Disclaimer This is not a validated score, but a hypothetical scheme to provoke thinking about the diagnosis of HFpEF in obesity. E/e’, early diastolic transmitral flow velocity/early diastolic mitral annular velocity; TR, tricuspid regurgitation; GLS, global longitudinal strain; LASr, left atrial strain reservoir phase; LAVh2, left atrial volume indexed by height2; LVMh2.7, left ventricular mass indexed by height2.7; m/w, men/women; RWT, relative wall thickness; NTproBNP, N-terminal pro B-type natriuretic peptide; BNP, B-type natriuretic peptide; AF, atrial fibrillation; HFpEF, heart failure with preserved ejection fraction.

References

    1. Obesity and overweight fact sheet World Health Organization. [Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
    1. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424–31. - PubMed
    1. Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279–86. - PMC - PubMed
    1. Kitzman DW, Shah SJ. The HFpEF obesity phenotype: the elephant in the room. J Am Coll Cardiol. 2016;68(2):200–3. - PubMed
    1. Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol. 2017;69(9):1129–42. - PMC - PubMed

LinkOut - more resources